Strategy for Cross-Protection among Shigella flexneri Serotypes
AUTOR(ES)
Noriega, Fernando R.
FONTE
American Society for Microbiology
RESUMO
Based upon the lipopolysaccharide (LPS) structure and antigenicity of Shigella group B, a strategy for broad cross-protection against 14 Shigella flexneri serotypes was designed. This strategy involves the use of two S. flexneri serotypes (2a and 3a), which together bear the all of the major antigenic group factors of this group. The novel attenuated strains used in these studies were S. flexneri 2a strain CVD 1207 (ΔguaB-A ΔvirG Δset1 Δsen) and S. flexneri 3a strain CVD 1211 (ΔguaB-A ΔvirG Δsen). Guinea pigs were immunized with an equal mixture of these strains and later challenged (Sereny test) with a wild-type S. flexneri serotype 1a, 1b, 2b, 4b, 5b, Y, or 6 strain of demonstrated virulence in the same model. Guinea pigs that were immunized with these two vaccine strains produced serum and mucosal antibodies that cross-reacted with all the S. flexneri serotypes tested (except of S. flexneri serotype 6) as assessed by enzyme-linked immunosorbent assay, immunoblotting, and slide agglutination. Furthermore, the combination vaccine conferred significant protection against challenge with S. flexneri serotypes 1b, 2b, 5b, and Y but not with serotypes 1a, 4b, or (as predicted) 6.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=96386Documentos Relacionados
- Cross-protection among feline caliciviruses.
- Cross-protection by Pseudomonas aeruginosa polysaccharides.
- Adoptive transfer of cross-protection among alphaviruses in mice requires allogeneic stimulation.
- Cross-protection between experimental anti-leptospirosis bacterins
- Cross-Protection Against Salmonella enteritidis Infection in Mice
